Quantcast

Latest MicroRNA Stories

2014-01-07 16:25:27

LA JOLLA, Calif., Jan. 7, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer of Regulus, will present a company overview at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2014 at 8:30 AM PST at the Westin St. Francis Hotel in San Francisco, CA....

2014-01-06 12:24:30

Studies Show New Methods for Early Diagnosis of Breast Cancer and Prediction of Its Spread in Women's Health Issue of Clinical Chemistry WASHINGTON, Jan. 6, 2014 /PRNewswire-USNewswire/ -- Two new papers in the "Advancing Women's Health" issue of Clinical Chemistry, the journal of AACC, show for the first time that measuring the amount of certain protein fragments and microRNAs in a woman's blood and breast tissue might enable the early diagnosis of breast cancer or prediction of its...

2013-12-21 23:01:31

Transparency Market Research Report Added "Global Micro-RNA Market - Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database. Browse Full Report:- http://www.transparencymarketresearch.com/micro-rna-market.html Albany, New York (PRWEB) December 21, 2013 Micro-RNA is a small non-coding RNA molecule which is a vital component of genetic regulation. Set of micro-RNAs are present in plants and animals functioning in gene expression process. They are...

2013-12-06 11:02:46

Findings have implications for treating severe treatment-refractory epilepsy, says Mount Sinai researcher New research from the Icahn School of Medicine at Mount Sinai shows that microRNA-128 is one of the strongest regulators of nerve cell excitability and motor activity, and that it does so by adjusting an entire neuronal signaling pathway. Published online Dec. 6 in the journal Science, the preclinical study suggests that developing new drugs for treatment-refractory epilepsy that...

2013-11-29 14:40:55

Cyclin D1 controls cell cycle progression and microRNA biogenesis through Dicer -- a new mechanism promoting breast cancer Cyclin D1, a protein that helps push a replicating cell through the cell cycle also mediates the processing and generation of mature microRNA (miRNA), according to new research publishing November 29 in Nature Communications. The research suggests that a protein strongly implicated in human cancer also governs the non-protein-coding genome. The non-coding genome,...

Autoimmune Disorders May Be Treated With A Little THC
2013-11-26 10:24:34

Rebekah Eliason for redOrbit.com – Your Universe Online New research has found evidence that THC (tetrahydrocannabinol), a principal component of marijuana, could be a beneficial treatment for autoimmune disorders. This is the first study of its kind to investigate how powerful little molecules known as microRNAs are affected by THC. RNAs are biological molecules that are important in coding, decoding, regulation and expression of genes. MicroRNAs were only recently discovered and are...

Researchers Show B Cells Can Deliver Potentially Therapeutic Bits Of Modified RNA
2013-11-26 06:59:03

University of California - San Diego Researchers at the University of California, San Diego School of Medicine have successfully targeted T lymphocytes – which play a central role in the body's immune response – with another type of white blood cell engineered to synthesize and deliver bits of non-coding RNA or microRNA (miRNA). The achievement in mice studies, published in this week's online early edition of the Proceedings of the National Academy of Sciences, may be the first step...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related